NTRK1 and hepatocellular carcinoma: Related with HCC cellular heterogeneity, previous studies have identified several therapy target molecules that might comprise HCC heterogeneity, particularly the Src family kinases (SFKs), a family of non-receptor tyrosine kinases (NRTKs).